Showing results (251-260 of 845) with videos related to

Sort By:
Pageof 85
Journal of the American Medical Directors Association|May 28, 2017
Integrated Care: Enhancing the Role of the Primary Health Care Professional in Preventing Functional Decline: A Systematic ReviewJohn E Morley, Hidenori Arai, Li Cao, et al.
Journal of Alzheimer'S Disease : JAD|May 26, 2019
Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment SubjectsSimon Dietlin, Maria Soto, Vera Kiyasova, et al.
Clinics in Geriatric Medicine|August 10, 2011
Clinical trials on sarcopenia: methodological issues regarding phase 3 trialsGabor Abellan van Kan, Wm Cameron Chumlea, Sophie Gillette-Guyonet, et al.
Alzheimer Disease and Associated Disorders|March 12, 2010
Gait and balance impairments in Alzheimer disease patientsVirginia Mazoteras Muñoz, Gabor Abellan van Kan, Christelle Cantet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2015
Assessing Alzheimer's disease patients' quality of life: Discrepancies between patient and caregiver perspectivesSandrine Andrieu, Nicola Coley, Yves Rolland, et al.
European Journal of Clinical Pharmacology|April 17, 2013
Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!François Montastruc, Virginie Gardette, Christelle Cantet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR StudyFrédéric Cortes, Fati Nourhashémi, Olivier Guérin, et al.
Presse Medicale (Paris, France : 1983)|November 14, 2008
[Vitamin D: skeletal and extra skeletal effects; recommendations for good practice]Karine Briot, Maurice Audran, Bernard Cortet, et al.
CNS Drugs|January 11, 2014
A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS studyVirginie Gardette, Maryse Lapeyre-Mestre, Antoine Piau, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 15, 2024
Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia-free older adultsEmmanuel Gonzalez-Bautista, Marie Momméja, Adelaïde de Mauléon, et al.
Pageof 85